1,593 Shares in Zoetis Inc. (NYSE:ZTS) Acquired by Swmg LLC

Swmg LLC purchased a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,593 shares of the company's stock, valued at approximately $265,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Cherry Creek Investment Advisors Inc. boosted its holdings in Zoetis by 2.0% during the third quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company's stock worth $590,000 after purchasing an additional 58 shares during the last quarter. Grove Bank & Trust boosted its holdings in Zoetis by 0.5% during the third quarter. Grove Bank & Trust now owns 11,763 shares of the company's stock worth $2,298,000 after purchasing an additional 61 shares during the last quarter. Hancock Whitney Corp boosted its holdings in Zoetis by 0.3% during the third quarter. Hancock Whitney Corp now owns 18,569 shares of the company's stock worth $3,628,000 after purchasing an additional 61 shares during the last quarter. Strategy Asset Managers LLC lifted its stake in Zoetis by 3.5% in the third quarter. Strategy Asset Managers LLC now owns 1,822 shares of the company's stock valued at $356,000 after acquiring an additional 62 shares during the last quarter. Finally, Procyon Advisors LLC lifted its stake in Zoetis by 1.4% in the fourth quarter. Procyon Advisors LLC now owns 4,712 shares of the company's stock valued at $768,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Wall Street Analysts Forecast Growth

ZTS has been the subject of a number of recent analyst reports. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an "outperform" rating and a $215.00 price target for the company. UBS Group initiated coverage on shares of Zoetis in a research note on Monday, December 9th. They issued a "neutral" rating and a $196.00 price target for the company. JPMorgan Chase & Co. increased their price target on shares of Zoetis from $225.00 to $230.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. Stifel Nicolaus cut their price target on shares of Zoetis from $210.00 to $180.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Finally, Leerink Partnrs raised shares of Zoetis to a "strong-buy" rating in a research report on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $215.00.

Zoetis Stock Performance

NYSE:ZTS traded down $0.18 during mid-day trading on Tuesday, reaching $171.76. 1,521,650 shares of the company's stock were exchanged, compared to its average volume of 2,627,942. Zoetis Inc. has a one year low of $144.80 and a one year high of $200.53. The firm has a market capitalization of $77.49 billion, a PE ratio of 32.27, a price-to-earnings-growth ratio of 2.72 and a beta of 0.90. The business's fifty day simple moving average is $169.48 and its two-hundred day simple moving average is $179.39. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping analysts' consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. Zoetis's revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the firm earned $1.36 earnings per share. Analysts anticipate that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. This is an increase from Zoetis's previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. Zoetis's dividend payout ratio is presently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.